Development and real-world implementation of a multicenter digital registry and management platform for chronic obstructive pulmonary disease: an observational implementation study

Background Patients with chronic obstructive pulmonary disease (COPD) require long-term, multidisciplinary management. Still, multicenter programs often face fragmented data capture, delayed quality control, incomplete follow-up, and limited visibility of remote monitoring data. We developed a multicenter digital registry and management platform to support data acquisition, quality control, role-specific reporting, and wearable-device monitoring. Methods We conducted an observational implementation study of a digital COPD registry and management platform deployed in a multicenter project in China. The platform integrated electronic data capture (EDC) data, questionnaire and examination records, cohort and physician–patient management, daily COPD exacerbation recognition tool (CERT) symptom reporting, wearable-device monitoring, role-specific WeChat reports, and hierarchical dashboards. We synchronized data from cloud sources to a local adjunct management database and transformed them into management indicators. We evaluated registry and organizational coverage, CERT activity, current wearable-device binding, recent 30-day wearable-monitoring events and alerts, questionnaire-index coverage, and production WeChat messaging using verified production data available on 10 September 2026. Results The platform indexed 2,894 included participants across 18 regional subcenters and 114 participating units, with 347 physicians linked to at least one recruited participant. The CERT index contained 26,092 valid records, and 277 participants had current wearable-device bindings. During the most recent 30-day monitoring period, the platform recorded 44,879 blood-pressure events, 8,685 abnormal blood-pressure or heart-rate alerts, and 2,417 low-oxygen-saturation alerts (SpO 2 <90%). The questionnaire index contained 3,373 question-index entries, and production messaging logs recorded 9,144 successfully sent WeChat reports. Conclusions This multicenter COPD digital registry and management platform integrated heterogeneous source data into an operational registry, converted registry data into management indicators, and delivered those indicators through role-specific reporting and hierarchical dashboards. The verified 10 September 2026 snapshot demonstrated registry-scale implementation across participating centers, physicians, symptom monitoring, wearable monitoring, and production messaging. Further work should evaluate workflow impact, user adoption, and patient outcomes. Trial registration The parent IMPACT COPD Cohort (China) was prospectively registered at ClinicalTrials.gov (NCT07382986) on 3 February 2026.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11474338/v1
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Development and real-world implementation of a multicenter digital registry and management platform for chronic obstructive pulmonary disease: an observational implementation study

Wanlu Sun, Manqi Zheng, Shuai Ren, 罗祖金 et al.
Research Square
Chronic Obstructive Pulmonary Disease (COPD) Research
preprint

Development and real-world implementation of a multicenter digital registry and management platform for chronic obstructive pulmonary disease: an observational implementation study

Wanlu Sun, Manqi Zheng, Shuai Ren, 罗祖金, Xiaoqian Shi, Ruoxuan Zhao, Tao Wang, Dan Zhang, Haichao Li, Xianbao Tang, Li An
preprint en

Abstract

Background Patients with chronic obstructive pulmonary disease (COPD) require long-term, multidisciplinary management. Still, multicenter programs often face fragmented data capture, delayed quality control, incomplete follow-up, and limited visibility of remote monitoring data. We developed a multicenter digital registry and management platform to support data acquisition, quality control, role-specific reporting, and wearable-device monitoring. Methods We conducted an observational implementation study of a digital COPD registry and management platform deployed in a multicenter project in China. The platform integrated electronic data capture (EDC) data, questionnaire and examination records, cohort and physician–patient management, daily COPD exacerbation recognition tool (CERT) symptom reporting, wearable-device monitoring, role-specific WeChat reports, and hierarchical dashboards. We synchronized data from cloud sources to a local adjunct management database and transformed them into management indicators. We evaluated registry and organizational coverage, CERT activity, current wearable-device binding, recent 30-day wearable-monitoring events and alerts, questionnaire-index coverage, and production WeChat messaging using verified production data available on 10 September 2026. Results The platform indexed 2,894 included participants across 18 regional subcenters and 114 participating units, with 347 physicians linked to at least one recruited participant. The CERT index contained 26,092 valid records, and 277 participants had current wearable-device bindings. During the most recent 30-day monitoring period, the platform recorded 44,879 blood-pressure events, 8,685 abnormal blood-pressure or heart-rate alerts, and 2,417 low-oxygen-saturation alerts (SpO 2 <90%). The questionnaire index contained 3,373 question-index entries, and production messaging logs recorded 9,144 successfully sent WeChat reports. Conclusions This multicenter COPD digital registry and management platform integrated heterogeneous source data into an operational registry, converted registry data into management indicators, and delivered those indicators through role-specific reporting and hierarchical dashboards. The verified 10 September 2026 snapshot demonstrated registry-scale implementation across participating centers, physicians, symptom monitoring, wearable monitoring, and production messaging. Further work should evaluate workflow impact, user adoption, and patient outcomes. Trial registration The parent IMPACT COPD Cohort (China) was prospectively registered at ClinicalTrials.gov (NCT07382986) on 3 February 2026.

Research Square
Beijing Institute of Technology (CN), Beijing Chao-Yang Hospital, Capital Medical University (CN)
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon